Coleman, C. (2017). Early detection and screening for breast cancer. Seminars in Oncology Nursing, 33, 141–155.

Article  Google Scholar 

Tsodikov, A., et al. (2017). Reconciling the effects of screening on prostate cancer mortality in the ERSPC and PLCO trials. Annals of Internal Medicine, 167, 449–455.

Article  Google Scholar 

Bivona, T. G., & Doebele, R. C. (2016). A framework for understanding and targeting residual disease in oncogene-driven solid cancers. Nature Medicine, 22, 472–478.

Article  CAS  Google Scholar 

Dasari, A., Grothey, A., & Kopetz, S. (2018). Circulating tumor DNA-defined minimal residual disease in solid tumors: Opportunities to accelerate the development of adjuvant therapies. Journal Clinical Oncology, 36(35), 3437.

Article  CAS  Google Scholar 

Sosa, M. S., Avivar-Valderas, A., Bragado, P., Wen, H. C., & Aguirre-Ghiso, J. A. (2011). ERK1/2 and p38alpha/beta signaling in tumor cell quiescence: Opportunities to control dormant residual disease. Clinical Cancer Research, 17, 5850–5857.

Article  CAS  Google Scholar 

Ghajar, C. M. (2015). Metastasis prevention by targeting the dormant niche. Nature Reviews Cancer, 15, 238–247.

Article  CAS  Google Scholar 

Giancotti, F. G. (2013). Mechanisms governing metastatic dormancy and reactivation. Cell, 155, 750–764.

Article  CAS  Google Scholar 

Aguirre-Ghiso, J. A. (2007). Models, mechanisms and clinical evidence for cancer dormancy. Nature Reviews Cancer, 7, 834–846.

Article  CAS  Google Scholar 

Sosa, M. S., Bragado, P., & Aguirre-Ghiso, J. A. (2014). Mechanisms of disseminated cancer cell dormancy: An awakening field. Nature Reviews Cancer, 14, 611–622.

Article  CAS  Google Scholar 

Nicolini, A., Ferrari, P., Rossi, G., & Carpi, A. (2018). Tumour growth and immune evasion as targets for a new strategy in advanced cancer. Endocrine-Related Cancer, 25, R577–R604.

Article  CAS  Google Scholar 

DeSantis, C. E., et al. (2014). Cancer treatment and survivorship statistics, 2014. CA: A Cancer Journal for Clinicians, 64, 252–271.

Google Scholar 

Jahanban-Esfahlan, R., et al. (2019). Tumor cell dormancy: Threat or opportunity in the fight against cancer. Cancers (Basel), 11, 1207.

Article  CAS  Google Scholar 

Yuhas, J. M., & Tarleton, A. E. (1978). Dormancy and spontaneous recurrence of human breast cancer in vitro. Cancer Research, 38, 3584–3589.

CAS  Google Scholar 

Romero, I., Garrido, F., & Garcia-Lora, A. M. (2014). Metastases in immune-mediated dormancy: A new opportunity for targeting cancer. Cancer Research, 74, 6750–6757.

Article  CAS  Google Scholar 

Luzzi, K. J., et al. (1998). Multistep nature of metastatic inefficiency: Dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. American Journal of Pathology, 153, 865–873.

Article  CAS  Google Scholar 

Bissell, M. J., & Hines, W. C. (2011). Why don’t we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nature Medicine, 17, 320–329.

Article  CAS  Google Scholar 

Uhr, J. W., & Pantel, K. (2011). Controversies in clinical cancer dormancy. Proc Natl Acad Sci U S A, 108, 12396–12400.

Article  CAS  Google Scholar 

Willis, R. (1934) The spread of tumours in the human body. By Rupert A. Willis. M.D., B.S., D.Sc. (Melbourne), 1934 London: J. & A. Churchill. 25s. net. BJS (British Journal of Surgery), 22, 196–196.

Hadfield, G. (1954). The dormant cancer cell. Br Med, J2, 607–610.

Article  Google Scholar 

Braun, S., et al. (2000). Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. New England Journal of Medicine, 342, 525–533.

Article  CAS  Google Scholar 

Braun, S., et al. (2005). A pooled analysis of bone marrow micrometastasis in breast cancer. New England Journal of Medicine, 353, 793–802.

Article  CAS  Google Scholar 

Friberg, S., & Nystrom, A. (2015). Cancer metastases: Early dissemination and late recurrences. Cancer Growth Metastasis, 8, 43–49.

Article  Google Scholar 

Morris-Stiff, G., et al. (2004). Transmission of donor melanoma to multiple organ transplant recipients. American Journal of Transplantation, 4, 444–446.

Article  CAS  Google Scholar 

Endo, H., & Inoue, M. (2019). Dormancy in cancer. Cancer Science, 110, 474–480.

Article  CAS  Google Scholar 

Gimbrone, M. A., Jr., Leapman, S. B., Cotran, R. S., & Folkman, J. (1972). Tumor dormancy in vivo by prevention of neovascularization. Journal of Experimental Medicine, 136, 261–276.

Article  Google Scholar 

Holmgren, L., O’Reilly, M. S., & Folkman, J. (1995). Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nature Medicine, 1, 149–153.

Article  CAS  Google Scholar 

Stewart, T. H. (1996). Immune mechanisms and tumor dormancy. Medicina (B Aires), 56: (Suppl 1), 74–82.

Goddard, E. T., Bozic, I., Riddell, S. R., & Ghajar, C. M. (2018). Dormant tumour cells, their niches and the influence of immunity. Nature Cell Biology, 20, 1240–1249.

Article  CAS  Google Scholar 

Rusciano, D., & Burger, M. M. (1992). Why do cancer cells metastasize into particular organs? BioEssays, 14, 185–194.

Article  CAS  Google Scholar 

Nicolson, G. L. (1988). Cancer metastasis: Tumor cell and host organ properties important in metastasis to specific secondary sites. Biochimica et Biophysica Acta, 948, 175–224.

CAS  Google Scholar 

Graf, A. H., Buchberger, W., Langmayr, H., & Schmid, K. W. (1988). Site preference of metastatic tumours of the brain. Virchows Arch A Pathol Anat Histopathol, 412, 493–498.

Article  CAS  Google Scholar 

Paget, S. (1989). The distribution of secondary growths in cancer of the breast 1889. Cancer Metastasis Rev, 8, 98–101.

CAS  Google Scholar 

Riihimäki, M., et al. (2014). Metastatic sites and survival in lung cancer. Lung Cancer, 86, 78–84.

Article  Google Scholar 

Talmadge, J. E., Donkor, M., & Scholar, E. (2007). Inflammatory cell infiltration of tumors: Jekyll or Hyde. Cancer and Metastasis Reviews, 26, 373–400.

Article  Google Scholar 

Tarin, D., et al. (1984). Mechanisms of human tumor metastasis studied in patients with peritoneovenous shunts. Cancer Research, 44, 3584–3592.

CAS  Google Scholar 

Fidler, I. J. (1970). Metastasis: Quantitative analysis of distribution and fate of tumor emboli labeled with 125 I-5-iodo-2′-deoxyuridine. Journal of the National Cancer Institute, 45, 773–782.

CAS  Google Scholar 

Riethdorf, S., et al. (2007). Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: A validation study of the cell search system. Clinical Cancer Research, 13, 920–928.

Article  CAS  Google Scholar 

Wang, C., et al. (2021). Improved prognostic stratification using circulating tumor cell clusters in patients with metastatic castration-resistant prostate cancer. Cancers (Basel), 13, 268.

Article  CAS  Google Scholar 

Klein, C. A. (2009). Parallel progression of primary tumours and metastases. Nature Reviews Cancer, 9, 302–312.

Article  CAS  Google Scholar 

Weiss, L. (1983). Random and nonrandom processes in metastasis, and metastatic inefficiency. Invasion and Metastasis, 3, 193–207.

CAS  Google Scholar 

Arnerlöv, C., et al. (1992). Breast carcinoma growth rate described by mammographic doubling time and S-phase fraction Correlations to clinical and histopathologic factors in a screened population. Cancer, 70, 1928–1934.

Article  Google Scholar 

Klein, C. A., et al. (2002). Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer. Lancet, 360, 683–689.

Article  CAS  Google Scholar 

Gruber, I. V., et al. (2016). Relationship between hematogenous tumor cell dissemination and cellular immunity in DCIS patients. Anticancer Research, 36, 2345–2351.

CAS  Google Scholar 

Sänger, N., et al. (2011). Disseminated tumor cells in the bone marrow of patients with ductal carcinoma in situ. International Journal of Cancer, 129, 2522–2526.

Article  Google Scholar 

Hu, Z., & Curtis, C. (2020). Looking backward in time to define the chronology of metastasis. Nature Communications, 11, 3213.

Article  CAS  Google Scholar 

Alix-Panabieres, C., & Pantel, K. (2014). Challenges in circulating tumour cell research. Nature Reviews Cancer, 14, 623–631.

Article  CAS  Google Scholar 

Dasgupta, A., Lim, A. R., & Ghajar, C. M. (2017). Circulating and disseminated tumor cells: Harbingers or initiators of metastasis? Molecular Oncology, 11, 40–61.

Article  Google Scholar 

Schardt, J. A., et al. (2005). Genomic analysis of single cytokeratin-positive cells from bone marrow reveals early mutational events in breast cancer. Cancer Cell, 8, 227–239.

Article  CAS  Google Scholar 

Schmidt-Kittler, O., et al. (2003). From latent disseminated cells to overt metastasis: Genetic analysis of systemic breast cancer progression. Proc Natl Acad Sci U S A, 100, 7737–7742.

Article  CAS  Google Scholar 

Gray, J. W. (2003). Evidence emerges for early metastasis and parallel evolution of primary and metastatic tumors. Cancer Cell, 4, 4–6.

Article  CAS